We found that down-regulation of SLC19A1 substantially decreases the rate of methotrexate uptake in neuroblastoma cells, indicating that RFC is also a major methotrexate uptake mechanism in neuroblastoma. Here, SLC19A1 is linked to neuroblastoma.